Sequana Medical NV
EBR:SEQUA.BR
0.93 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Revenue
| 0.712 | 0.923 | 0.371 | 0.963 | 0.971 | 1.029 | 1.304 | 1.489 | 1.685 |
Cost of Revenue
| 4.866 | 0.205 | 0.077 | 0.202 | 0.198 | 0.158 | 0.212 | 0.32 | 0.359 |
Gross Profit
| -4.154 | 0.718 | 0.294 | 0.761 | 0.773 | 0.871 | 1.092 | 1.168 | 1.326 |
Gross Profit Ratio
| -5.833 | 0.778 | 0.793 | 0.79 | 0.796 | 0.846 | 0.837 | 0.785 | 0.787 |
Reseach & Development Expenses
| 5.277 | 7.707 | 6.14 | 4.437 | 2.521 | 0.935 | 1.174 | 1.146 | 0.995 |
General & Administrative Expenses
| 6.943 | 6.687 | 5.098 | 4.417 | 4.264 | 5.761 | 1.988 | 4.059 | 3.286 |
Selling & Marketing Expenses
| 1.799 | 2.24 | 2.079 | 2.322 | 2.838 | 2.445 | 1.506 | 3.337 | 2.988 |
SG&A
| 20.322 | 8.927 | 7.177 | 6.738 | 7.102 | 8.206 | 3.494 | 7.396 | 6.274 |
Other Expenses
| -5.277 | 19.885 | 15.73 | 11.794 | 7.634 | 0.074 | 0.004 | 0.021 | 0.264 |
Operating Expenses
| 25.599 | 28.813 | 22.907 | 18.532 | 14.736 | 13.948 | 8.51 | 15.113 | 12.681 |
Operating Income
| -29.753 | -28.387 | -22.649 | -17.874 | -14.071 | -13.038 | -7.571 | -13.744 | -11.424 |
Operating Income Ratio
| -41.778 | -30.765 | -61.132 | -18.555 | -14.497 | -12.668 | -5.806 | -9.232 | -6.78 |
Total Other Income Expenses Net
| -2.972 | -1.99 | -0.573 | -1.076 | -0.771 | -0.922 | -0.636 | -0.19 | -0.089 |
Income Before Tax
| -32.725 | -30.376 | -23.222 | -18.949 | -14.841 | -13.96 | -8.207 | -13.934 | -11.512 |
Income Before Tax Ratio
| -45.951 | -32.922 | -62.677 | -19.672 | -15.29 | -13.564 | -6.294 | -9.359 | -6.832 |
Income Tax Expense
| -0.162 | 0.387 | 0.393 | 0.157 | 0.136 | 0.024 | 0.018 | 0.041 | 0.044 |
Net Income
| -32.564 | -30.763 | -23.615 | -19.106 | -14.977 | -13.983 | -8.225 | -13.975 | -11.557 |
Net Income Ratio
| -45.724 | -33.341 | -63.738 | -19.835 | -15.431 | -13.587 | -6.308 | -9.387 | -6.859 |
EPS
| -1.22 | -1.35 | -1.3 | -1.25 | -1.22 | -1.02 | -0.6 | -1.02 | -0.85 |
EPS Diluted
| -1.22 | -1.35 | -1.3 | -1.25 | -1.22 | -1.02 | -0.6 | -1.02 | -0.85 |
EBITDA
| -29.092 | -28.075 | -22.241 | -17.567 | -13.827 | -12.957 | -7.493 | -13.664 | -11.377 |
EBITDA Ratio
| -40.85 | -30.428 | -60.029 | -18.237 | -14.245 | -12.59 | -5.747 | -9.178 | -6.752 |